Resources

Recognizing advocacy’s potential to impact maternal, newborn, and child health, a group of civil society organizations (CSOs) working on these issues in Kakamega County, Kenya, teamed up to establish the "Kakamega County Maternal, Newborn, and Child Health CSOs Alliance" in 2016. Partially sponsored by PATH, the alliance exists to coordinate advocacy efforts around improved access to health care services for women and children in Kakamega county. This brochure provides an overview of the Alliance's work, mission, and advocacy objectives.

PATH comments on the Executive Board's agenda item on transforming the approach to health in the digital age. PATH recommends that WHO catalyze and align global support for country priorities and goals around data and digital, encourages the development of prioritized and costed country investment roadmaps, and the development of a singular governance approach for data and digital within WHO.

PATH comments on the WHO Executive Board's agenda item on the global strategy and plan of action for public health, innovation, and intellectual property. PATH urges the importance of addressing regulatory harmonization as a barrier to health technologies reaching those who need them most.

PATH comments on the Executive Board's agenda item on accelerating the elimination of cervical cancer as a global public health problem. PATH recommends that the strategy include HPV vaccines as a key WHO "best buy", and urges that efforts to prevent cervical cancer be accompanied by efforts to strengthen national health information systems. PATH also calls on WHO to endorse self-sampling for HPV testing, accelerated access to lower-cost point-of-care screening tests, treatment, and strategic procurement.

PATH comments on the WHO Executive Board's 2020 agenda item on the global immunization strategy. PATH reflects that immunization programming is a key component and entry point for primary health care, and calls on member states to appropriately increase domestic funding levels for immunization within the context of primary health care. PATH also commends the WHO resolution's focus on the need for investment in vaccine R&D.